Home  /  Health & Fitness Apps  / CA125
CA125 Application icon

CA125 1.0

1 MB / 0+ Downloads / Rating 5.0 - 1 reviews


See previous versions

CA125, developed and published by Cherish Women’s Cancer Foundation, has released its latest version, 1.0, on 2017-09-20. This app falls under the Health & Fitness category on the Google Play Store and has achieved over 10 installs. It currently holds an overall rating of 5.0, based on 1 reviews.

CA125 APK available on this page is compatible with all Android devices that meet the required specifications (Android 2.3+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.ca125tracker

Updated: 7 years ago

Developer Name: Cherish Women’s Cancer Foundation

Category: Health & Fitness

Installation Instructions

This article outlines two straightforward methods for installing CA125 on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

Previous Versions

CA125 1.0
2017-09-20 / 1 MB / Android 2.3+

About this app

Cherish Women's Cancer Foundation successfully gained a grant to develop this Smartphone Application to assist ovarian and endometrial (uterine) cancer patients feel more in control of their experience post-diagnosis. This App allows patients to input details given to them by their gynaecological oncologist so they can see quickly and easily progress with the tumour markers in their blood.

Proceeds from the sale of this App goes to Cherish to continue its work in the ovarian cancer and endometrial (uterine) cancer space. In addition to providing much needed funding towards clinical trials into these cancer types, this App also collects non-identifying data as a valuable research tool for researchers in Australia to better design solutions for women diagnosed with ovarian and endometrial (uterine) cancer. It's this secondary benefit which is of immeasurable value to the future of research into prevention, diagnosis and treatment that can not be done without the support of such women.

We thank you for helping Cherish to achieve its goal to provide kinder ways to treat women.

Should you wish to find out more about Cherish, please visit our website www.cherish.org.au